SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 19, 2000, Pages 5354-5358

Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice

(4) Guinness, M E a Kenney, J L a Reiss, M a Lacy, J a

a YALE UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE;

ANIMAL; APOPTOSIS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSPLANTATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENES, BCL-2; HERPESVIRUS 4, HUMAN; HUMAN; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, SCID; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034306971 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (35)

References (37)

1
- 0000157121
- Epstein-Barr virus - Biology, pathogenesis, and medical aspects
- B.N. Fields, D.M. Knipe, and R.M. Chanock (eds.), Virology. New York: Raven Press
- (1990) , pp. 1921-1958
- Miller, G.¹

2
- 0007855686
- Transformation by the virus in vitro
- M.A. Epstein and B.G. Achong (eds.), The Epstein-Barr Virus. New York: Springer-Verlag
- (1979) , pp. 205-223
- Pope, J.H.¹

3
- 0026038352
- Immortalizing genes of Epstein-Barr virus
- K. Maramorosch, F.A. Murphy, and J.A. Shatkin (eds.), Advances in Viral Research. San Diego, CA: Academic Press. Inc.
- (1991) , pp. 19-55
- Middleton, T.¹ Gahn, T.A.² Martin, J.M.³ Sugden, B.⁴

4
- 0000462866
- Epstein-Barr virusits replication
- B. N. Fields, D.M. Knipe, and R.M. Chanock (eds.), Virology. New York: Raven Press
- (1990) , pp. 1889-1920
- Kieff, E.¹ Liebowitz, D.²

5
- 0026510327
- Epstein-Barr virus in B lymphocytes: Viral gene expression and function in latency
- (1992) Adv. Cancer Res. , vol.58 , pp. 1-26
- Rogers, R.P.¹ Strominger, J.L.² Speck, S.H.³

6
- 0025834279
- Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation
- (1991) J. Virol. , vol.65 , pp. 2545-2554
- Cohen, J.I.¹ Wang, F.² Keiff, E.³

7
- 0024375760
- Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
- (1989) Nature (Lond.) , vol.340 , pp. 393-397
- Hammerschmidt, W.¹ Sugden, B.²

8
- 0027449255
- Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 9150-9154
- Kaye, K.M.¹ Izumi, K.M.² Kieff, E.³

9
- 0027479649
- Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
- (1993) J. Virol. , vol.76 , pp. 2014-2025
- Tompkinson, B.¹ Robertson, E.² Kieff, E.³

10
- 0023879695
- Transformation of BALB 3T3 cells by the BNLFI gene of Epstein-Barr virus
- (1988) Oncogene , vol.2 , pp. 461-467
- Baichwal, V.R.¹ Sugden, B.²

11
- 0022309824
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
- (1985) Cell , vol.43 , pp. 831-840
- Wang, D.¹ Liebowitz, D.² Kieff, E.³

12
- 0025342480
- Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
- (1990) J. Virol. , vol.64 , pp. 2309-2318
- Wang, F.¹ Gregory, C.² Sample, C.³ Rowe, M.⁴ Liebowitz, D.⁵ Murray, R.⁶ Rickinson, A.⁷ Kieff, E.⁸

13
- 0023693708
- Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity
- (1988) J. Virol. , vol.62 , pp. 4173-4184
- Wang, D.¹ Liebowitz, D.² Wang, F.³ Gregory, C.⁴ Rickinson, A.⁵ Larson, R.⁶ Springer, T.⁷ Kieff, E.⁸

14
- 0026072991
- Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis
- (1991) Nature (Lond.) , vol.349 , pp. 612-614
- Gregory, C.D.¹ Dive, C.² Henderson, S.³ Smith, C.A.⁴ Williams, G.T.⁵ Gordon, J.⁶ Rickinson, A.B.⁷

15
- 0025772343
- Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
- (1991) Cell , vol.65 , pp. 1107-1115
- Henderson, S.¹ Rowe, M.² Gregory, C.³ Croom-Carter, D.⁴ Wang, F.⁵ Longnecker, R.⁶ Kieff, E.⁷ Rickinson, A.⁸

16
- 0028856396
- The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest
- (1995) Oncogene , vol.11 , pp. 1027-1031
- Okan, I.¹ Wang, Y.² Chen, F.³ Hu, L.-F.⁴ Imreh, S.⁵ Klein, G.⁶ Wiman, K.G.⁷

17
- 0029844368
- Bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders
- (1996) J. Pathol. , vol.180 , pp. 254-258
- Chetty, R.¹ Biddolph, S.² Kaldamanis, L.³ Cary, N.⁴ Stewart, S.⁵ Giatromanolaki, A.⁶ Gatter, K.⁷

18
- 0030058818
- BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders
- (1996) Blood , vol.87 , pp. 706-711
- Murray, P.G.¹ Swinnen, L.J.² Constandinou, C.M.³ Pyle, J.M.⁴ Carr, T.J.⁵ Hardwick, J.M.⁶ Ambinder, R.F.⁷

19
- 0031907428
- Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
- (1998) Nat. Med. , vol.4 , pp. 232-234
- Jansen, B.¹ Schlagbauer-Wadl, H.² Brown, B.D.³ Bryan, R.N.⁴ Van Elsas, A.⁵ Muller, M.⁶ Wolff, K.⁷ Eichler, H.-G.⁸ Pehamberger, H.⁹

20
- 0030888664
- BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
- (1997) Lancet , vol.349 , pp. 1137-1141
- Webb, A.¹ Cunningham, D.² Cotter, F.³ Clarke, P.A.⁴ DiStefano, F.⁵ Ross, P.⁶ Corbo, M.⁷ Dziewanowska, Z.⁸

21
- 0025266571
- Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice
- (1990) J. Clin. Investig. , vol.85 , pp. 1333-1337
- Cannon, M.J.¹ Pisa, P.² Fox, R.I.³ Cooper, N.R.⁴

22
- 0026053945
- Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man
- (1991) J. Exp. Med. , vol.173 , pp. 147-158
- Rowe, M.¹ Young, L.S.² Crocker, J.³ Stokes, H.⁴ Henderson, S.⁵ Rickinson, A.B.⁶

23
- 0032170456
- Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP-1) suppresses LMP-1 and Bcl-2 expression and promotes apoptosis in EBV-irmmortalized B cells
- (1998) Blood , vol.92 , pp. 1721-1727
- Kenney, J.L.¹ Guinness, M.E.² Curiel, T.³ Lacy, J.⁴

24
- 0029619116
- Labeling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation
- (1995) Cell Proliferation , vol.28 , pp. 572-579
- Li, X.¹ Darzynkiewicz, Z.²

25
- 0028066802
- Antisense oligodeoxynucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model
- (1994) Oncogene , vol.9 , pp. 3049-3055
- Cotter, F.E.¹ Johnson, P.² Hall, P.³ Pocock, C.⁴ Al Mahdi, N.⁵ Cowell, J.K.⁶ Morgan, G.⁷

26
- 0028060247
- Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression
- (1994) Antisense Res. Dev. , vol.4 , pp. 71-79
- Kitada, S.¹ Takayama, S.² De Riel, K.³ Tanaka, S.⁴ Reed, J.C.⁵

27
- 0027377107
- Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity, and causes tumor regression
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 9901-9905
- Higgins, K.A.¹ Perez, J.R.² Coleman, T.A.³ Dirshkind, K.⁴ McComas, W.A.⁵ Sarmiento, U.M.⁶ Rosen, C.R.⁷ Narayanan, R.⁸

28
- 0023677838
- The diagnosis and treatment of post-transplant lymphoproliferative disorders
- (1988) Curr. Probl. Surg. , vol.25 , pp. 367-472
- Nalesnik, M.A.¹ Mahowka, L.² Starzl, T.E.³

29
- 0030951471
- Post-transplant EBV induced lymphoproliferative disorders
- (1997) Leuk. Lymphoma , vol.25 , pp. 1-8
- Lucas, K.G.¹ Pollak, K.E.² Emanuel, D.J.³

30
- 0032867015
- Mechanisms and therapeutic applications of immune stimulatory CpG DNA
- (1999) Pharmacol. Ther. , vol.84 , pp. 113-120
- Hartmann, G.¹

31
- 0004582004
- CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 15553-15558
- Brazolot Millan, C.L.¹ Weeratna, R.² Krieg, A.M.³ Siegrist, C.A.⁴ Davis, H.L.⁵

32
- 0030239828
- Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
- (1996) J. Immunol. , vol.157 , pp. 1840-1845
- Ballas, Z.K.¹ Rasmussen, W.L.² Krieg, A.M.³

33
- 0032526607
- CpG oligodeoxynucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
- (1999) J. Immunol. , vol.160 , pp. 5898-5906
- Yi, A.K.¹ Chang, M.² Peckham, D.W.³ Krieg, A.M.⁴ Ashman, R.F.⁵

34
- 0030900680
- Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma
- (1997) Blood , vol.89 , pp. 2994-2998
- Wooldridge, J.E.¹ Ballas, Z.² Krieg, A.M.³ Weinter, G.J.⁴

35
- 0023677838
- The diagnosis and treatment of post-transplant lymphoproliferative disorders
- (1988) Curr. Probl. Surg. , vol.25 , pp. 371-472
- Nalesnik, M.A.¹ Makowa, L.² Starzyl, T.E.³

36
- 0030951471
- Post-transplant EBV-induced lymphoproliferative disorders
- (1997) Leuk. Lymphoma , vol.25 , pp. 1-8
- Lucas, K.¹ PollokEmanuel, D.J.²

37
- 0032930274
- Rational management of post-transplant lymphoproliferative disorder in pediatric recipients
- (1999) J. Pediatr. Surg. , vol.34 , pp. 112-116
- Colomban, P.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.